Distal cholangiocarcinoma is a bile duct carcinoma arising in the pancreatic segment of the common bile duct (CBD) or near the ampulla of Vater. It constitutes 20-30% of all cholangiocarcinomas. Clinically presents with obstructive jaundice, weight loss, and 'painless jaundice' — Courvoisier's sign may be positive (gallbladder distension due to distal obstruction). Can mimic pancreatic head carcinoma; in differential diagnosis, determining whether the tumor arises from the CBD wall or pancreatic parenchyma is critical. MRCP shows stricture in distal CBD with proximal biliary dilation, CT shows wall thickening/mass in distal CBD and delayed enhancement as diagnostic findings. Double duct sign (both bile and pancreatic duct dilation) frequently accompanies. Whipple procedure (pancreaticoduodenectomy) is standard surgical treatment with better prognosis than hilar type.
Age Range
45-80
Peak Age
65
Gender
Male predominant
Prevalence
Uncommon
Distal cholangiocarcinoma is an adenocarcinoma arising from bile duct epithelium in the pancreatic segment of the CBD. Like hilar type, it shows desmoplastic reaction and periductal infiltrative growth pattern is predominant. Distal CBD obstruction causes dilation of the entire proximal biliary tree (intrahepatic ducts + hilar region + proximal CBD) — unlike hilar obstruction, distal type shows dilation of both CBD and intrahepatic ducts. When pancreatic duct obstruction accompanies, 'double duct sign' (both bile and pancreatic duct dilated) forms — this finding is shared by ampullary region pathologies (distal cholangiocarcinoma, pancreatic head carcinoma, ampullary carcinoma). Delayed phase enhancement reflects late contrast uptake by desmoplastic fibrotic stroma. In differentiation from pancreatic head carcinoma: distal cholangiocarcinoma arises from CBD wall (eccentric wall thickening, CBD lumen-centered mass), pancreatic head carcinoma arises from parenchyma (externally compresses CBD, hypodense mass in pancreatic parenchyma). Positive Courvoisier's sign (palpable, painless, distended gallbladder) points to distal obstruction and supports differentiation from hilar type.
Simultaneous dilation of both bile duct (CBD) and pancreatic duct — classic radiologic finding of ampullary region obstruction. Seen in distal cholangiocarcinoma, pancreatic head carcinoma, and ampullary carcinoma. Two parallel dilated ducts seen at the pancreatic head.
Focal stricture in distal CBD (pancreatic segment) with dilation of proximal CBD and intrahepatic bile ducts on MRCP. Stricture is usually limited to a short segment (<2 cm) with abrupt transition. If pancreatic duct obstruction accompanies, 'double duct sign' is seen. Gallbladder may be distended (Courvoisier). Hilar region is normal caliber — distinguishing from hilar cholangiocarcinoma.
Report Sentence
Focal stricture in the distal CBD with dilation of the entire proximal biliary tree is identified on MRCP, consistent with distal cholangiocarcinoma; accompanying pancreatic duct dilation forms a 'double duct sign'.
Eccentric wall thickening or small periductal mass in the distal CBD shows progressive enhancement on delayed phase CT. The tumor that minimally enhances in arterial and portal venous phases gains marked enhancement in delayed phase (3-5 minutes). Mass is usually small (<2 cm) with configuration narrowing or obstructing the CBD lumen. Pancreatic parenchyma may be normal or show upstream atrophy.
Report Sentence
Eccentric thickening/mass in the distal CBD wall showing progressive delayed phase enhancement is identified, consistent with distal cholangiocarcinoma.
Simultaneous dilation of both CBD and pancreatic duct on portal venous phase CT — 'double duct sign'. CBD >7 mm and pancreatic duct >3 mm dilated. Two dilated ducts course in parallel converging at the pancreatic head. This finding suggests ampullary region pathologies (distal cholangiocarcinoma, pancreatic head carcinoma, ampullary carcinoma) and carries clinical urgency. Mass or wall thickening should be sought at the obstruction point on CT.
Report Sentence
Simultaneous dilation of both CBD and pancreatic duct (double duct sign) is identified, suggesting ampullary region pathology; obstructive lesion at the distal CBD level should be evaluated.
CBD dilation (>7 mm) and distended gallbladder (Courvoisier's sign) on US are indicators of distal obstruction. Accompanying intrahepatic bile duct dilation is seen. The tumor in distal CBD is usually not directly visible on US (assessment of distal CBD is limited by duodenal gas artifact). However, detection of CBD dilation establishes indication for further imaging (MRCP, CT).
Report Sentence
CBD dilation and distended gallbladder (Courvoisier's sign) are identified, suggesting distal biliary obstruction; further evaluation with MRCP is recommended.
Focal diffusion restriction at the distal CBD level on DWI — high signal on high b-value, low signal on ADC. Adds value to conventional sequences for detecting small periductal masses. Helpful in differential from benign strictures (stone-related, inflammatory) — diffusion restriction is usually absent in benign strictures.
Report Sentence
Focal diffusion restriction at the distal CBD level on DWI is identified, a finding supporting malignant stricture/cholangiocarcinoma.
Abrupt termination or narrowing of the distal CBD is imaged against the background of enhancing pancreatic parenchyma on arterial phase CT. Small periductal soft tissue separating from normal pancreatic parenchyma may be seen. In arterial phase, the tumor is usually hypoenhancing (lower enhancement than pancreatic parenchyma). This phase best demonstrates the contrast difference between pancreatic parenchyma and tumor.
Report Sentence
Abrupt termination of the distal CBD at the pancreatic head level with surrounding hypoenhancing periductal soft tissue is identified on arterial phase, suggestive of distal cholangiocarcinoma.
Criteria
Most common form. Periductal infiltration along CBD wall and wall thickening. May not have distinct mass formation — stricture predominates.
Distinct Features
Delayed enhancement prominent. Desmoplastic reaction allows small tumor to create large obstructive effect. May be difficult to detect on CT — MRCP and DWI are complementary.
Criteria
Less common. Distinct solid mass formation at distal CBD level. Closely mimics pancreatic head carcinoma.
Distinct Features
Mass is CBD lumen-centered dilating CBD, while pancreatic head carcinoma is pancreatic parenchyma-centered compressing CBD externally. MRI attempts to show CBD wall origin. EUS-FNA may be diagnostic.
Criteria
Rarest form. Polypoid/papillary mass within CBD lumen. Better prognosis than other types — slow growth, later invasion.
Distinct Features
T2 hypointense filling defect within CBD lumen on MRCP. Enhancing intraluminal polypoid structure on CT. Higher resectability rate and better 5-year survival.
Distinguishing Feature
In pancreatic head carcinoma, mass is pancreatic parenchyma-centered and externally compresses CBD; in distal cholangiocarcinoma, mass arises from CBD wall (eccentric thickening, lumen-centered). Relationship between CBD and mass should be evaluated on MRI.
Distinguishing Feature
In choledocholithiasis, T2 hypointense filling defect (stone) with crescent-shaped bile signal around it ('meniscus sign') on MRCP; no enhancing mass. In cholangiocarcinoma, enhancing soft tissue mass with delayed enhancement pattern.
Distinguishing Feature
In hilar cholangiocarcinoma, stricture is at hepatic confluence with normal caliber distal CBD; in distal type, stricture is in pancreatic CBD segment with entire proximal biliary tree dilated, gallbladder may be distended.
Distinguishing Feature
In benign stricture, smooth contoured, symmetric narrowing without diffusion restriction on DWI; minimal/regular enhancement. In malignant stricture, irregular, asymmetric narrowing, periductal mass, delayed enhancement, and diffusion restriction.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralWhipple procedure (pancreaticoduodenectomy) is standard surgical treatment for distal cholangiocarcinoma with higher resectability rate (60-80%) and better prognosis than hilar type (5-year survival 20-40%). Preoperative biliary drainage (ERCP stent or PTBD) may be performed to improve liver function in jaundiced patients. Chemotherapy (gemcitabine + cisplatin) and biliary stenting palliative for inoperable cases. EUS-FNA can be used for preoperative histologic diagnosis but not mandatory when surgery is indicated.
Distal cholangiocarcinoma is treated with surgical resection (Whipple procedure). Has better prognosis than hilar cholangiocarcinoma (higher resectability rate). Histological diagnosis obtained with EUS-FNA. Malignancy should be excluded in the presence of double duct sign.